Representation of people with aphasia in randomized controlled trials of acute stroke interventions

International Journal of Stroke

Volumn 9, Issue 2, 2014, Pages 174-182

  Ali, Myzoon ^a   Bath, Philip M ^b   Lyden, Patrick D ^c   Bernhardt, J ^d   Brady, Marian ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Aphasia; Attrition; Consent; Enrollment; Inclusion; Stroke

Indexed keywords

ADULT; AGE DISTRIBUTION; APHASIA; ARTICLE; CENTRAL AMERICA; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; DISEASE SEVERITY; ETHNICITY; FEMALE; GEOGRAPHICAL VARIATION (SPECIES); HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOUTH AMERICA; YOUNG ADULT;

APHASIA; ATTRITION; CONSENT; ENROLLMENT; INCLUSION; STROKE;

AGED; AGED, 80 AND OVER; APHASIA; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHY; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; STROKE;

EID: 84892739648     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12043     Document Type: Article

References (40)

1. Dickey L, Kagan A, Lindsay MP, Fang J, Rowland A, Black S. Incidence and profile of inpatient stroke-induced aphasia in Ontario, Canada. Arch Phys Med Rehabil 2010; 91:196-202.
2. Ellis C, Simpson AN, Bonilha H, Mauldin PD, Simpson KN. The one-year attributable cost of poststroke aphasia. Stroke 2012; 43:1429-1431. doi: 10.1161/STROKEAHA.111.647339.
3. Pedersen PM, Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Aphasia in acute stroke: incidence, determinants, and recovery. Ann Neurol 1995; 38:659-666.
4. Engelter ST, Gostynski M, Papa Setal. Epidemiology of aphasia attributable to first ischemic stroke. Incidence, severity, fluency, etiology, and thrombolysis. Stroke 2006; 37:1379-1384.
5. Townend E, Brady M, KcLaughlan K. Exclusion and inclusion criteria for people with aphasia in studies of depression after stroke: a systematic review and future recommendations. Neuroepidemiology 2007; 29:1-17.
6. Dalemans R, de Witte LP, Lemmens J, van den Heuvel WJA, Wade D. Measures for rating social participation in people with aphasia: a systematic review. Clin Rehabil 2008; 22:542-555.
7. Dalemans R, Wade D, van den Heuvel WJA, de Witte LP. Facilitating the participation of people with aphasia in research: a description of strategies. Clin Rehabil 2009; 23:948-959.
8. Alexander MP. Clinical determination of mental competence. A theory and a retrospective study. Arch Neurol 1988; 45:23-26.
9. Stein J, Brady Wagner LC. Is informed consent a 'yes or no' response? Enhancing the shared decision-making process for persons with aphasia. Top Stroke Rehabil 2006; 13:42-46.
10. Kagan A. Revealing the competence of aphasic adults through conversation: a challenge to health professionals. Top Stroke Rehabil 1995; 2:15-28.
11. Thomas SA, Lincoln NB. Predictors of emotional distress after stroke. Stroke 2008; 39:1240-1245.
12. Jerome D, Dehail P, Daviet JCetal. Stroke in the under-75S: expectations, concerns and needs. Ann Phys Rehabil Med 2009; 52:525-537.
13. Paterson BL, Thorne SE, Canam C, Jillings C. Meta-Study of Qualitative Health Research: A Practical Guide to Meta-Analysis and Meta-Synthesis. Thousand Oaks, CA, Sage, 2001.
14. UK Government Legislation. Mental Capacity Act 2005. 2012. http://www.Legislation.Gov.uk/ukpga/2005/9/section/32 (Last accessed April 17, 2012).
15. Applebaum PS, Grisso T. Assessing patients' capacities to consent to treatment. New Engl J Med 1988; 319:1635-1638.
16. Holland AL, Halper AS. Talking to individuals with aphasia: a challenge to the rehabilitation team. Top Stroke Rehabil 1996; 2:27-37.
17. Langhorne P, Stott DJ, Knight A, Bernhardt J, Barer D, Watkins C. Very early rehabilitation or intensive telemetry after stroke: a pilot randomised trial. Cerebrovasc Dis 2010; 29:352-360.
18. Ellis G, Rodger J, McAlpine C, Langhorne P. The impact of stroke nurse specialist input on risk factor modification: a randomised controlled trial. Age Ageing 2005; 34:389-392.
19. Thorne S, Paterson B, Acorn S, Canam C, Joachim G, Jillings C. Chronic illness experience: insights from a metastudy. Qual Health Res 2002; 12:437-452.
20. Flaherty ML, Karlawish J, Khoury JC, Kleindorfer D, Woo D, Broderick JP. How important is surrogate consent for stroke research? Neurology 2008; 71:1566-1571.
21. Dani KA, McCormick MT, Muir KW. Brain lesion volume and capacity for consent in stroke trials: potential regulatory barriers to theuse of surrogate markers. Stroke 2008; 39:2336-2340.
22. Scotland. Adults with incapacity (Scotland) Act 2000-excerpt. Bull Med Ethics 2000; 157:8-11.
23. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. 2012. http://www.eortc.be/services/doc/clinical-eu-directive-04-april-01.pdf (Last accessed April 16, 2012).
24. Food and Drug Administration. Protection of human subjects; informed consent-FDA. Final rule. Fed Regist 1996; 61:51498-51533.
25. Biros MH, Fish SS, Lewis RJ. Implementing the food and drug administration's final rule for waiver of informed consent in certain emergency research circumstances. Acad Emerg Med 1999; 6:1272-1282.
26. Ali M, Bath P, Brady Metal. Development, expansion and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke 2012; 7:133-138.
27. Melo TP, Bogousslavsky J, van Melle G, Regli F. Pure motor stroke: a reappraisal. Neurology 1992; 42:789-798.
28. Hadidi N, Buckwalter K, Lindquist R, Rangen C. Lessons learned in recruitment and retention of stroke survivors. J Neurosci Nurs 2012; 44:105-110.
29. Rose FC, Kasner SE. Informed consent: the rate-limiting step in acute stroke trials. Front Neurol 2011; 2:1-9.
30. Lees KR, Bath PMW, Schellinger PDetal. Contemporary outcome measures in acute stroke research: choice of primary outcome measure. Stroke 2012; 43:1163-1170.
31. Duncan PW, Zorowitz R, Bates Betal. Management of adult stroke rehabilitation care: a clinical practice guideline. Stroke 2005; 36:e100-143.
32. Laska AC, Bartfai A, Hellblom A, Murray V, Kahan T. Clinical and prognostic properties of standardized and functional aphasia assessments. J Rehabil Med 2007; 39:387-392.
33. Lezak M. Neuropsychological Assessment. New York, Oxford University Press, 1983.
34. Lyden P, Raman R, Liu L, Emr M, Warren M, Marler J. NIHSS Certification is Reliable Across Multiple Venues. Stroke 2009 July; 40:2507-2511.
35. Quinn TJ, Lees KR, Hardemark HG, Dawson J, Walters MR. Initial experience of a digital training resource for modified Rankin Scale assessment in clinical trials. Stroke 2007; 38:2257-2261.
36. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q 1971; 49:509-538.
37. Howson CP, Reddy HK, Ryan TJ, Bale JR. Control Cardiovascular Diseases in Developing Countries. Washington DC, National Academy Press, 1998.
38. Yusuf S, Reddy KS, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general consideration, the epidemiology transition, risk factors and impact of urbanization. Circulation 2001; 104:2746-2753.
39. Zhao D, Liu J, Wang Wetal. Epidemiological transition of stroke in China: twenty-one year observational study from the Sino MONICA-Beijing project. Stroke 2008; 39:1668-1674.
40. Marshall PA. Informed consent in international health research. J Empir Res Hum Res Ethics 2006; 1:25-42.